Sulforaphane,
does it really help with Slower biological aging and extended healthspan or lifespan in healthy adults?
research showsSulforaphane is rated ? for slowing biological aging or extending healthspan or lifespan in healthy adults. Completed human intervention trials identified in the search evaluated short-term safety, absorption and metabolism, environmental-exposure biomarkers, metabolic disease, or condition-specific symptoms; no completed result directly assessed aging rate, healthspan, lifespan, or mortality. Lifespan signals exist in nonhuman models such as Caenorhabditis elegans. The absence of a completed human trial on the claimed endpoints requires a null score.
ads claimMarketing connects Nrf2 activation, antioxidant and detoxification biomarkers, and nematode lifespan extension to reversal of human aging and longer life. Human absorption, safety, or condition-specific biomarker results do not substitute for healthspan or lifespan outcomes.
Useful facts when choosing a product
- Sulforaphane is an isothiocyanate formed when myrosinase converts glucoraphanin from broccoli sprouts, and products differ in precursor and active-enzyme composition.
- Human trials have used sulforaphane, sulforaphane-rich extract, glucoraphanin precursor, and broccoli-sprout beverages, producing nonuniform actual exposure.
- Short-term human trials generally found acceptable tolerability, although gastrointestinal discomfort and taste or odor complaints can occur.
- Potential thyroid effects of crucifer-derived compounds have been discussed, but a controlled 12-week trial found no harmful change in thyroid function or autoimmunity markers.
What the research actually shows
The 2006 phase 1 trial by Shapiro and colleagues administered broccoli-sprout glucosinolate or isothiocyanate extracts to 12 healthy adults for seven days and evaluated safety, tolerance, and metabolism without a consistent toxicity signal. The 2019 analysis by Chartoumpekis and colleagues reported that a 12-week broccoli-sprout beverage did not harm thyroid function or autoimmunity measures in 45 healthy women. The 2021 study by Qi and colleagues extended lifespan and functional measures in Caenorhabditis elegans but was not a human trial. No completed human trial found in the search used an epigenetic clock, phenotypic age, frailty-free survival, disability-free survival, healthspan, or mortality as a sulforaphane efficacy endpoint.
Why this is classified as ?
No completed sulforaphane intervention result directly evaluating biological aging rate, healthspan, total lifespan, or mortality in healthy adults was identified. Safety, metabolism, biomarkers, and nonhuman lifespan evidence do not address the claimed endpoints, so boundary rule ④ yields ? with a null score.
Counterpoint. Completed human safety and metabolism trials mean the compound has been studied in people, but they are not completed trials of the requested aging and longevity efficacy endpoints.
Rejudgment record. New verdict — Separated completed human safety, absorption, metabolism, and condition-specific biomarker studies from Caenorhabditis elegans lifespan research, did not transfer them to human aging-rate, healthspan, or lifespan efficacy, and applied boundary rule ④ because no completed human intervention result addressed the direct endpoints
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Slower biological aging | ? | No completed human intervention result directly assessing an epigenetic clock or aging rate was identified. |
| Extended healthspan | ? | No completed human trial used a direct healthspan endpoint such as frailty-free or disability-free survival. |
| Extended lifespan | ? | No completed sulforaphane intervention trial evaluated total lifespan or mortality in humans. |
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Shapiro TA et al. 2006 | Phase 1 randomized double-blind placebo-controlled safety and metabolism trial | 12 | Public funding from the United States NIH and NCI | Seven-day safety, tolerability, dithiocarbamate excretion, and liver and thyroid tests | No consistent toxicity signal appeared, but aging rate, healthspan, and lifespan were not assessed. | Human safety evidence with endpoint mismatch |
| Chartoumpekis DV et al. 2019 | Thyroid-safety analysis of a 12-week randomized controlled trial | 45 | Academic and public support including the United States NIH and NIEHS | Thyroid function tests and thyroid autoimmunity | No harmful change in thyroid function or autoimmunity was observed, but no aging or lifespan efficacy endpoint was included. | Intermediate-duration safety evidence, not direct efficacy |
| Qi Z et al. 2021 | Caenorhabditis elegans lifespan and mechanism experiment | 9 | Academic research support | Nematode lifespan, mobility, feeding, lipofuscin, and signaling pathways | Lifespan and functional measures improved in nematodes, but this was not a human intervention result. | Nonhuman mechanistic evidence that cannot establish human lifespan |
Receipt — 3 References
All 3 cited sources were verified for existence at the original page (as of 2026-07-23).
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-23 · Corrections: none
Cite this verdict
[Chamgap] Sulforaphane x slower biological aging and extended healthspan or lifespan — Evidence Grade ?. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/antioxidant-aging/sulforaphane-biological-aging-healthspan-lifespan/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.